Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06999590 · ClinicalTrials.gov registry record · Phase 4
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers
A Phase 4 study of Ulcer and Pressure Ulcer, sponsored by Tiger Biosciences.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06999590 is a Phase 4 study of Ulcer and Pressure Ulcer that is actively recruiting participants, run by Tiger Biosciences. The registered enrollment target is 500 participants, above the 178-participant average among 13 other Ulcer trials with a reported enrollment target (181% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06999590, a Phase 4 study of Ulcer and Pressure Ulcer, is actively recruiting participants, sponsored by Tiger Biosciences.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study it to evaluate several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER ACApatch™
- OTHER caregraFT™
Study Locations (1)
Pennsylvania
- Serena Group - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2027-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06999590
The ClinicalTrials.gov registry entry for NCT06999590 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 178-participant average among 13 other Ulcer trials with a reported enrollment target (181% higher). The listed sponsor is Tiger Biosciences, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Ulcer appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT06999590 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06999590 about?
NCT06999590 is a clinical study titled "Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers". The purpose of this study it to evaluate several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.
What is the current status of trial NCT06999590?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2025-05-20. Estimated completion is 2027-05.
What conditions does trial NCT06999590 study?
This clinical trial studies the following conditions: Ulcer, Pressure Ulcer, Pressure Injury, Ulcer, Pressure.
What interventions are being tested in trial NCT06999590?
The interventions under investigation include: Standard of Care (OTHER), ACApatch™ (OTHER), caregraFT™ (OTHER).
Who is sponsoring clinical trial NCT06999590?
This trial is sponsored by Tiger Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06999590 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.
RECRUITING
-
Total Contact Soft Cast in Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.